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ABSTRACT 
W.H.O. recognized Ayurveda as the first and foremost system of medicine 
in the world. Ayurveda is the ocean of knowledge of life science. It is still 
existing and fighting with the present situations because of its efficiency. 
In the present trend, plants are extensively used by man for maintenance 
of health and for the treatment of myriad of illness. Now days, due to 
sedentary lifestyle, industrialization, urbanization, lack of non spiritual 
health and lack of exercise especially change in food habits lead to clinical 
entity known as hyperlipidemia which is the major cause of many other 
disorders. Kadamba is one of the easily available medicinal plants which 
is mentioned in Brihatrayee and Nighantus like Raja Nighantu, Bhava 
prakasha etc. In Sushruta Samhita, it was mentioned in Nyagrodadi gana 
and Rodradi gana in Sutra Sthana 38th chapter. These drugs have Karmas 
like Kaphaghna, Medohara, Varnya, Vishaghna, Sthambhana, Asthi 
Bhaghna sandhanakara and indicated in diseases like Medoroga, 
Prameha, Yoniroga etc. It is an attempt to prove the clinical efficacy of leaf 
along with bark to conserve the trees. The present study evaluated the 
clinical efficacy of Kadamba (Anthocephalus Cadamba (Roxb.) Miq) in 
Medoroga w.s.r. to Hyperlipidemia and also comparative efficacy of bark 
and leaf by studying in 30 patients divided into 2 groups for a period of 
40 days and results are assessed and observed that Kadamba 
(Anthocephalus cadamba (Roxb.) Miq) bark and leaf are clinically 
effective in Medoroga and leaf is little more efficacious than bark and it is 
a drug of choice in the management of Medoroga. 
 
INTRODUCTION 
In today’s world, sedentary lifestyle, faulty 
dietary habits including ready- to- eat fast food, 
stress during the work results into the disturbance 
of digestion and metabolism ultimately leading to 
many lifestyle disorders. Medoroga is one of these 
diseases which have taken a toll on whole 
generation’s health. It is emerging as an important 
health problem in India also. The symptoms of 
Medoroga are Kshudra Swasa, Pipasa Atiyoga, Kshut 
Atimatra, Sareera Dourghandya, Anga Saithilya, 
Atinidra and Utsahahani.[1] Here Medoroga can be 
termed as Hyperlipidemia which provides the 
platform for so many diseases like hypertension, 
ischemic heart diseases, diabetes, osteoarthritis, 
infertility, impotency as well as psychological 
disorders like stress, anxiety and depression etc. 
Hyperlipidemia is the term used to denote raised 
serum levels of one or more of total cholesterol, 
low-density lipoprotein cholesterol, triglycerides, or 
both total cholesterol and triglyceride (combined 
hyperlipidemia). However, there is no precise 
terminology for hyperlipidemia in Ayurveda. 
Various attempts are made to use distinctive 
nomenclature to denote the word Hyperlipidemia is 
Medoroga or Medodosha. In Sushruta Samhita, 
Kadamba was mentioned in Nyagrodadi gana and 
Rodradi gana in Sutra Sthana[2]. These drugs have 
karmas like Kaphaghna, Medohara, Varnya, 
Vishaghna, Sthambhana, Asthi Bhaghna 
sandhanakara and indicated in diseases like 
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Medoroga, Prameha, Yoniroga etc. Several single 
drugs are described in Ayurveda for the treatment 
of Medoroga. Thus, considering the lack of definite 
Ayurveda comprehension as well as the magnitude 
hyperlipidemia is causing life threatening diseases, 
the present clinical study has been planned with 
Bark and Leaf of Kadamba. The drug Kadamba 
(Anthocephalus Cadamba (Roxb.) Miq) is selected in 
Medoroga for the present study as it is nontoxic, 
cost effective, can be administered orally, it has Sita 
Virya, Katu Vipaka, Kashaya, Tikta Rasas and Kapha 
Medohara[3] property and many research activities 
experimentally proved the hypolipidemic activity.[4-
6] 
 
 
 
 
Aim and Objective 
1. To Evaluate Clinical efficacy of Kadamba 
(Anthocephalus cadamba (Roxb.) Miq) in the 
management of Medoroga. 
2. To Evaluate the Comparative Clinical efficacy of 
Kadamba (Anthocephalus cadamba (Roxb.) Miq) 
bark and leaf in the management of Medoroga. 
Material and Methods 
Kadamba (Anthocephalus Cadamba (Roxb.) 
Miq) bark and leaf are collected from Vikarabad 
forest near Hyderabad, Telangana state. Genuine 
and good quality material which are free from any 
worm infection were cut and separated, washed, 
dried in shade and stored in air tight dried 
container. Fine powder is prepared by using 
pulveriser and stored in airtight containers. This 
powder is packed in zip lock covers and is used for 
the purpose of clinical study. 
     
Figure 1: Bark   Figure 2: Bark Powder 
     
Figure 3: Leaf   Figure 4: Leaf Powder 
Selection criteria: A total of 30 patients are 
selected randomly from OP of Dravyaguna 
department of PG unit, Dr. BRKR Govt. Ayurvedic 
Hospital, Erragadda, Hyderabad. The treatment is 
planned for 40 days with follow up of 20 days and 
as per necessity. The patients are divided into 2 
groups A and B. Group A was treated with Kadamba 
Bark fine powder and Group B with Kadamba leaf 
fine powder at a dose of 3gms twice a day with 
lukewarm water. The patients are categorized 
according to their age, sex, occupation, socio 
economic status, diet, cardinal symptoms. 
Inclusive criteria: Patients were selected for the 
study irrespective of sex, occupation according to 
the following criteria for inclusion. 
1) Subjects with signs and symptoms of Medoroga – 
Angagaurava, Atisweda, Alasya, Atinidra, Kshudra 
swasa, Ati kshut, Ati pipasa. 
2) Age group above 20 years and below 60 years. 
3) Raised levels of Lipid Profile. (TC, LDL-C, VLDL-C, 
Triglycerides). 
Exclusive criteria 
Certain patients were excluded from the study as 
per the below criteria:  
1) Age below 20 years and above 60 years  
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2) Obesity secondary to or associated with 
Hypothyroidism, Hypertension, Diabetes 
Mellitus or Cushing’s syndrome.  
3) Any concomitant serious disorder of the liver, 
kidneys, heart, lungs or other organs. 
4) Pregnant and Lactating women 
5) Person undergoing treatment for any other 
serious illness like Carcinomas. 
Subjective Parameters: 1) Angagaurava, 2) 
Atinidra, 3) Atisweda, 4) Utsahahani, 5) Ksut 
atimatra, 6) Pipasa atiyoga, 7) Kshudraswasa. 
Objective parameters 
Lipid Profile: Serum Total Cholesterol, HDL, LDL, 
VLDL, Serum triglycerides 
Method of assessment: The patients registered for 
clinical trial were examined clinically and the 
findings were recorded in a specially prepared case 
sheet. Patients were advised for laboratory 
investigations before and after treatment. All the 
patients are advised to come for review at regular 
intervals of 20 days till 40 days. After 40 days of 
treatment the results were noted.  
Assessment Criteria: The improvement of the 
patients was assessed by adopting standard scoring 
pattern for signs and symptoms of the disease. The 
assessment of subjective parameters was done by 
giving individual scores to signs and symptoms and 
percentage of result was assessed in each group for 
each sign or symptom and for every patient. The 
gradation of signs and symptoms as per classics is 
given by sign 1 (mild), 2 (moderate) and 3 (severe). 
The total signs are counted. The absence of signs 
and symptoms is given by 0 sign. For each and 
every character individual scoring was given for 
before and after treatment and percentage relief 
was calculated. According to the severity of the 
symptoms grading were given as below: 
Score Assessment 
Subjective parameters 
0 - No Symptom 
1 - Mild 
2 - Moderate 
3 - Severe 
Criteria of result assessment 
1. Mild relief : 25% to 50% 
2. Moderate relief : 51% to 75% 
3. Good relief : 76% to 100% 
Objective Parameters 
The assessment of objective parameters 
was based on the below table. The value of each 
entity of the lipid profile after treatment is marked 
as per the table and improvement is assessed. 
Criteria for diagnosing hyperlipidemia and 
assessment of lipid profile are according to NCEP 
guidelines.  
Table 1: Criteria For Diagnosing Hyperlipidemia and Assessment of Lipid Profile (NCEP Guidelines)[7] 
Total Cholesterol- TC (mg/dl) 
< 200 Desirable  
200-239 Borderline 
>240 High  
LDL Cholesterol (mg/dl) 
<100 Optimal  
100-129 Near/Above Optimal 
130-159 Borderline 
160-189 High  
>190 Very High 
HDL Cholesterol (mg/dl) 
>59 Great  
45-59 Desirable  
<40 Risk  
Triglycerides TG (mg/dl) 
<150 Normal 
150-199 Borderline  
200-499 High  
500 Very High 
VLDL Cholesterol(mg/dl) 
< 32 Desirable 
>32 High 
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Statistical Analysis: Clinical symptoms and laboratory parameters are analyzed using appropriate 
statistical methods. Wilcoxon Test and Paired T test are the tests used to analyze statistical significance in 
the present study.  
Results and Discussion 
Subjective Parameters 
In Group A out of 15 patients Utsahahani was exhibited by 13 (86.67%) patients, Kshudraswasa was 
exhibited by 13 (86.67%) patients, Atinidra was exhibited by 12 (80%) patients, Kshutatimatra was 
exhibited by 11 (73.33%) patients, Sandhisoola was exhibited by 14 (93.33%) patients, Angasaithilya was 
exhibited by 11 (73.33%) patients. 
In Group B out of 15 patients Utsahahani was exhibited by 13(86.67%) patients, Kshudraswasa was 
exhibited by 13 (86.67%) patients, Atinidra was exhibited by 12 (80%) patients, Kshutatimatra was 
exhibited by 12 (80%) patients, Sandhisoola was exhibited by 15 (100%) of patients, Angasaithilya was 
exhibited by 13 (86.67%) patients respectively. 
Table 2: Symptomatic Relief Before And After Treatment In Group-A 
Symptoms B.T A.T Difference Percentage 
Utsahahani 33 11 22 66.67% 
Kshudraswasa 32 4 28 87.5% 
Atinidra 24 9 15 62.5% 
Kshutatimatra 24 10 14 58.33% 
Pipasaatiyoga 32 6 26 81.25% 
Sandhisoola 33 5 26 84.84% 
Angasaithilyam 25 8 17 68% 
B.T – Before Treatment, A.T – After Treatment 
After assessment of the signs and symptoms and analysis of the results, it was observed that the percentage 
relief of symptoms In Group-A with Kadamba bark powder was of Utsahahani-66.67%, Kshudra swasa- 
87.5%, Atinidra-62.5%, Kshutatimatra-58.3%, Pipasaatiyoga-81.25%, Sandhisoola-84.84%, Angasaithilyam- 
68% respectively. 
Table 3: Symptomatic Relief Before and After Treatment In Group-B 
Symptoms B.T A.T Difference Percentage 
Utsahahani 27 5 22 81.48% 
Kshudraswasa 28 3 25 89.3% 
Atinidra 19 6 13 68.42% 
Kshutatimatra 15 5 10 66.7% 
Pipasaatiyoga 18 6 12 66.7% 
Sandhisoola 34 5 29 85.3% 
Angasaithilyam 24 6 18 75% 
B.T – Before Treatment, A.T – After Treatment 
In Group-B with Kadamba leaf powder, the individual symptoms inferred the percentage of relief 
Utsahahani- 81.48%, Kshudra swasa-89.3%, Atinidra-68.42%, Kshutatimatra-66.7%, Pipasaatiyoga-66.7%, 
Sandhisoola-85.3%, Angasaithilyam-75% respectively.  
Table 4: Statistical Data Showing Symptomatic Relief Before and After Treatment with Kadamba 
Bark Powder in Group-A 
S.No. Symptoms 
MEAN ± SD 
MD P value 
BT AT 
1 Utsahahani 2.2±0.94 0.73±0.70 1.47 0.00096 
2 Kshudraswasa 2.1±0.83 0.25±0.45 1.85 0.00096 
3 Atinidra 1.6±0.91 0.6±0.74 1.0 0.00338 
4 Pipasaatiyoga 2.07±0.96 0.40±0.63 1.67 0.00222 
5 Kshutatimatra 1.80±1.01 0.67±0.49 1.13 0.00222 
6 Sandhisoola  2.20±0.68 0.33±0.49 1.87 0.00064 
7 Angasaithilyam 1.67±1.11 0.53±0.52 1.14 0.00512 
B.T – Before Treatment, A.T – After Treatment, MD – Mean Difference 
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The statistical significance of results was calculated from the “P” values of each parameter which 
helps in coming to a conclusion in assessing the efficacy of Kadamba bark and leaf powder. For the Kadamba 
bark powder in Group-A the “P” value observed in Utsahahaani (0.00096), Kshudraswasa (0.00096), Atinidra 
(0.00338), Pipasaatiyoga (0.00222), Kshutatimatra (0.00222), Sandhisoola (0.00064), Angasaithilyam 
(0.00512) and is statistically highly significant.   
Table 5: Statistical Data Showing Symptomatic Relief Before and After Treatment with Kadamba Leaf 
Powder in Group-B 
S.No. Symptoms 
MEAN ± SD 
MD P value 
BT AT 
1 Utsahahani 1.80±0.94 0.33±0.49 1.47 0.00148 
2 Kshudraswasa 1.87±1.06 0.20±0.41 1.67 0.00148 
3 Atinidra 1.27±0.80 0.40±0.51 0.87 0.00338 
4 Pipasaatiyoga 1.20±1.01 0.40±0.51 0.80 0.00512 
5 Kshutatimatra 1.00±0.65 0.33±0.49 0.67 0.00512 
6 Sandhisoola  2.27±0.80 0.33±0.49 1.93 0.00064 
7 Angasaithilyam 1.60±0.91 0.40±0.51 1.20 0.00222 
B.T – Before Treatment, A.T – After Treatment, MD – Mean Difference, SD – Standard Deviation 
For Kadamba leaf powder in Group-B ‘’P” value observed in Utsahahaani (0.00148), Kshudraswasa 
(0.00148), Atinidra (0.00338), Pipasaatiyoga (0.00512), Kshutatimatra (0.00512), Sandhisoola (0.00064) 
Angasaithilyam (0.00222) and is statistically highly significant. 
The effect of therapy showed maximum improvement of signs and symptoms with good response was 
observed in 46.67% of patients, moderate response was observed in 53.33% of patients in Group-A treated 
with Kadamba bark powder. 
In Group-B maximum improvement of signs and symptoms with good response was observed in 60% of 
patients, moderate response was observed in 40% of patients treated with Kadamba leaf powder. 
Objective Parameters: The percentage change or difference obtained in the objective parameters after the 
treatment with Kadamba bark powder, in Group-A is total cholesterol is 23.238%, HDL-Cholesterol is 
24.468%, LDL-C is 26.236%, VLDL-C is 22.138%, Triglycerides is 25.927%.  
With Kadamba leaf powder, in Group-B the objective parameters inferred the percentage change in total 
cholesterol is 24.811%, HDL-Cholesterol is 28.681%, LDL-C is 32.667%, VLDL-C is 43.718%, Triglycerides is 
57.299 %.  
Table 6: Response of Patients before and after Treatment With Respect to Lipid Profile In 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-Normal value, D-Desirable, BL- Borderline High, H-High, AB-Abnormal 
 Group-A  Group-B 
Lipid profile (mg/dl) 
Kadamba Bark Kadamba Leaf 
BT AT BT AT 
Total Cholesterol 
N 3 (20%) 10 (66.67%) 3 (20%) 9 (60%) 
BL 4 (26.67%) 3 (20%) 1 (6.67%) 6 (40%) 
H 8 (53.33%) 2 (13.33 %) 11 (73.33%) 0 
Triglycerides 
N 8 (53.33%) 12 (80%) 5 (33.33%) 13 (86.67%) 
BL 1 (6.67%) 2 (13.33%) 0 (0%) 2 (13.33%) 
H 6 (40 %) 1 (6.67%) 10 (66.67%) 0(0%) 
HDL 
N 0 0 1 (6.67%) 4 (26.67%) 
D 9 (60%) 14 (93.33%) 8 (53.33%) 10 (66.66%) 
H 6 (40%) 1 (6.67%) 6(40%) 1 (6.67%) 
LDL 
N 0 6 (40%) 3 (20%) 6 (40%) 
D 4 (26.67%) 7 (46.67%) 1 (6.67%) 4 (26.67%) 
BL 3 (20%) 0 (0%) 1 (6.67%) 4 (26.67%) 
H 8 (53.33%) 2 (13.33%) 10 (6.67%) 1 (6.66%) 
VLDL 
N 9 (60%) 13 (86.67%) 10 (66.6%) 15 (100%) 
H 6 (40%) 2 (13.33%) 5 (33.33%) 0 (0%) 
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Table 7: Statistical Analysis of Lipid Profiles Before and After the Treatment in Group-A 
B.T – Before Treatment, A.T – After Treatment, MD – Mean Difference 
The statistical analysis of objective parameters showed that the “P” value of the lipid profile in Group-A 
including total cholesterol levels is <0.00001, on HDL levels is 0.00001, on LDL levels is <0.00001, on VLDL 
levels is 0.0037, on Triglycerides is 0.0012 which are conventionally extremely statistically significant for 
the entire lipid profile.  
Table 8: Statistical Analysis of Lipid Profiles Before and After the Treatment in Group-B 
B.T – Before Treatment, A.T – After Treatment, MD – Mean Difference 
“P” value of effect of Kadamba leaf powder in Group –B patients on total cholesterol levels is <0.00001, on 
HDL levels is <0.00001, on LDL levels is <0.00001, on VLDL levels is <0.00001, on Triglycerides is 0.0005 
which are extremely statistically significant for the entire lipid profile. 
In Group-A normal lipid levels before treatment are present in none of the patients regarding to some 
particular lipid entities and after treatment 9 (60%) patients have normal lipid values. The abnormal lipid 
levels before treatment are present in 15 (100%) patients and after treatment 6 (40%) patients only have 
an abnormal lipid values. So it may be assumed that the treatment with Kadamba bark powder inferred the 
increase in the number of normal lipid level patients. 
In Group-B normal lipid levels before treatment are present in none of the patients regarding to some 
particular lipid entities and after treatment 13 (8.67%) patients have normal lipid values. The abnormal 
lipid levels before treatment are present in 15 (100%) patients and after treatment 2 (13.33%) patients only 
have an abnormal lipid values. So it may be assumed that the treatment with Kadamba leaf powder inferred 
the increase in the number of normal lipid level patients. 
Table 9: Comparative Overall Results Percentage Relief of the Cardinal Symptoms in Group A and 
Group B 
Response of patients Group A Group B 
 No % No % 
Mild response 0 0 0 0 
Moderate response 8 53.33 6 40 
Good response 7 46.67 9 60 
Total 15 100 15 100 
Table 10: Comparative Overall Response of the Patients before and After the Treatment Based on 
Lipid Profile in Group-A & Group-B 
Lipid 
Profile 
Treatment with Bark No. of patients Treatment with Leaf No. of patients 
BT AT BT AT 
Normal 0 (0%) 9 (60%) 0(0%) 13(86.67%) 
Abnormal 15 (100%) 6 (40%) 15(100%) 2(13.33%) 
B.T – Before Treatment, A.T – After Treatment 
Lipid Profile 
(mg/dl) 
Mean Change 
% 
 MD  t-value p-Value 
BT AT 
Total Cholesterol  233.53±26.49 179.27±37.43 23.238 54.27 8.3260 < 0.00001 
HDL 41.40±6.23 51.53±6.14 24.468 10.13 5.2656 = 0.00001 
LDL 157.53±32.06 116.20±28.36 26.236 41.33 8.1260 < 0.00001 
VLDL 38.53±13.50 30.00±13.94 22.138 8.53 3.4731 =0.0037 
Triglycerides 180.00±79.62 133.33±60.65 25.927 46.67 4.0378 =0.0012 
Lipid Profile 
(mg/dl) 
Mean Change 
% 
 MD  t-value p-Value 
BT AT 
Total Cholesterol  237.27±39.33 178.40±39.41 24.811 58.87 7.6003 < 0.00001 
HDL 40.20±3.86 51.73±7.96 28.681 11.53 6.1618 <0.00001 
LDL 156.73±45.40 105.53±40.08 32.667 51.20 8.5095 < 0.00001 
VLDL 38.13±12.82 21.47±4.24 43.718 16.66 6.0469 < 0.00001 
Triglycerides 258.87±128.39 110.53±23.28 57.299 148.33 4.4837 =0.0005 
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Hence it may be assumed that drug 
Kadamba bark and leaf powder will be useful in 
reducing the total cholesterol, LDL-Cholesterol, 
Triglycerides, VLDL Cholesterol levels and 
increasing HDL-Cholesterol levels. 
Probable Mode of Action 
According to Ayurveda, the drug action is 
understood based on its composition like Rasa 
Panchakas. Due to its Tikta, Kashaya rasas, 
Kadamba has Lekhana property, Ruksha guna acts 
as Kapha hara and Sosana and Katu vipaka acts as 
Kapha samaka because of these properties it acts as 
Medohara. Tikta Rasa has the property of Ama 
pachana and thus they are capable of rectifying 
digestion and metabolism at different levels in 
order to achieve Dhatusamyata and Mala samyata. 
Thus reducing the lipids i.e., cholesterol levels 
bringing into normal state.  
CONCLUSION 
Both bark and leaf of Kadamba were 
effective in bringing back the symptomatology 
explained in Ayurveda for Medoroga and the 
abnormal lipid profile to normalcy laid down in 
modern classics with special reference to 
Hyperlipidaemia. But by statistical analysis it can be 
concluded that leaf is little more efficacious than 
bark in relieving signs and symptoms of Medoroga 
and bringing back the normalcy of lipid profile. I 
conclude that Kadamba (Anthocephalus cadamba 
(Roxb.) Miq) bark and leaf are clinically effective in 
Medoroga and leaf is little more efficacious than 
bark and it is a drug of choice in the management of 
Medoroga. This humble trial was conducted in a 
small sample with limited parameters. There is 
need for further research in large samples with 
more parameters for analyzing its efficacy in 
Medoroga which will be beneficial to the humanity 
at large.  
REFERENCES 
1. Madhavakara Krita Madhava Nidana with Vijaya 
Rakshitaand Srikantadatta Virachita 
Madhukosha Vyakhya, published by Choukamba 
Samskrita Samthana, Varanasi, 20th edition 1993, 
vol 11, Medoroga Nidana page 28-30. 
2. Prof.P.V.sharma, Susrutha Samhita, Volume I, 
Varanasi, Chowkambha Orientalia, Reprint 
year2004. P- 357, 362. 
3. Dr.Indradev Tripathi, Raja Nighantu of Pandita 
Narahari, 4th edition, Varanasi, Chowkambha 
Krishnadas Academy, 2006, Pg-447. 
4. Atul Dubey, Satish Nayak and D.C.Goupale – 
Anthocephalus Cadamba A Review- PHCOG.J, jan 
2011, Vol-2, Issue 18, P- 75. 
5. Vishnu Kumar, Mohammad Mubin Khan, Ashok 
Kumar Khanna, Ranjana Singh, Sushma singh – 
Lipid Lowering Activity of Anthocephalus indicus 
Root in Hyperlipidemic Rats – Medicinal 
Chemistry Research, June 2008, Volume 17, 
Issue 2-7, P- 152–158. 
6. Suman Acharyya, Gouri Kumar Dasha, Mohd. 
Syafiq Abdullah -Antihyperglycemic and 
antilipidemic activity of Anthocephalus cadamba 
(roxb.) Miq. roots, European Journal of 
Experimental Biology, 2013, 3(3):116-120.  
7. National Cholesterol Education Program-ATP IV 
Guidelines (NCEP), (2012). 
 
 
 
 
 
 
Disclaimer: AYUSHDHARA is solely owned by Mahadev Publications - A non-profit publications, dedicated to publish quality 
research, while every effort has been taken to verify the accuracy of the content published in our Journal. AYUSHDHARA cannot 
accept any responsibility or liability for the articles content which are published. The views expressed in articles by our contributing 
authors are not necessarily those of AYUSHDHARA editor or editorial board members. 
 
Cite this article as:  
Swetha.Ch, V.Narasimha. Comparative Clinical Study of Kadamba (Anthocephalus Cadamba (Roxb.) 
Miq) Bark and Leaf In Medoroga. AYUSHDHARA, 2019;6(2): 2095-2101. 
Source of support: Nil, Conflict of interest: None Declared 
 
